Stoke Therapeutics, Inc. (STOK) Max Pain Analysis

Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.

Stoke Therapeutics, Inc. (STOK) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.97B, listed on NASDAQ, employing roughly 128 people, carrying a beta of 1.20 to the broader market. Stoke Therapeutics, Inc. Led by Ian F. Smith, public since 2019-06-19.

Snapshot as of May 15, 2026.

Spot Price
$30.09
Total OI
4.0K

Learn how max pain is reported and how to read the data →